A press release has been issued by Satsuma Pharmaceuticals, Inc.

  • Business

Announcement Date: June 13, 2024 (U.S. time)
Details: Our consolidated subsidiary, Satsuma, will present a poster at the American Headache Society (American Headache Society: AHS) meeting in San Diego, USA, regarding the intranasal migraine medication (development code: STS101). For more details Satsuma's website Please see.

Back to News List